整合分析揭示痛风CD14单核细胞的多层面炎症机制
研究对8例痛风患者和6例年龄性别匹配的健康对照的外周血单个核细胞进行单细胞RNA测序,并用公共数据集验证。发现缺氧相关通路(包括HIF1A)调控CD14单核细胞产生白细胞介素-1β,CLEC12A在所有CD14单核细胞亚簇中显著下调。一个高表达S100A8/A9/A12的S100Ahigh CD14单核细胞亚簇驱动NLRP3和CLEC7A炎症小体活化及前列腺素分泌,脂肪酸代谢相关基因也促进该亚簇分泌前列腺素。
要点
- 缺氧相关通路(包括HIF1A)是痛风CD14单核细胞产生白细胞介素-1β的关键调控因素。
- S100Ahigh CD14单核细胞亚簇驱动NLRP3和CLEC7A炎症小体活化及前列腺素分泌。
- 痛风GWAS优先基因提示脂肪酸代谢促进S100Ahigh单核细胞分泌前列腺素。
核心结论
- 研究为CD14单核细胞在痛风发病中的作用提供新见解,尤其涉及缺氧和脂肪酸代谢通路的贡献,并提示痛风精准医学的潜在治疗靶点。
研究设计与样本
- 对8例痛风患者和6例年龄及性别匹配的健康对照的外周血单个核细胞进行单细胞RNA测序,并用公共数据集验证。
- 开展差异基因表达和通路富集分析,以识别痛风的关键分子调控因子和细胞亚簇。
主要发现
- 在分子层面,鉴定出缺氧相关通路(包括HIF1A)是痛风CD14单核细胞产生白细胞介素-1β的关键调控因素。
- 观察到CLEC12A在所有CD14单核细胞亚簇中显著下调。
- 在细胞层面,发现一个以S100A8/A9/A12高表达为特征、与炎症和代谢通路相关的S100Ahigh CD14单核细胞亚簇,驱动NLRP3和CLEC7A炎症小体活化以及前列腺素分泌。
- 单钠尿酸盐晶体体外刺激显示差异表达基因富集于S100Ahigh单核细胞,突显这些通路在驱动痛风炎症中的协同作用。
- 痛风全基因组关联研究优先基因强调脂肪酸代谢在炎症中的作用,促进S100Ahigh单核细胞分泌前列腺素。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Gout, prevalent inflammatory arthritis caused by urate crystal deposition, involves immune cell activation, yet the precise role of CD14 monocytes in initiating the inflammatory response is poorly understood. This study aimed to characterise the molecular and cellular landscape of CD14 monocytes in gout using single-cell transcriptomic analysis. METHODS: Single-cell RNA sequencing was performed on peripheral blood mononuclear cells from 8 gout patients and 6 age- and sex-matched healthy controls. The findings were validated using publicly available datasets. Differential gene expression and pathway enrichment analyses were conducted to identify gout's key molecular regulators and cellular subclusters. RESULTS: At the molecular level, we identified hypoxia-related pathways, including HIF1A, as key regulators of interleukin-1β production in CD14 monocytes in gout. We also observed significant downregulation of CLEC12A across all CD14 monocyte subclusters. At the cellular level, an S100Ahigh CD14 monocyte subcluster, characterized by high expression of S100A8/A9/A12 and linked to inflammatory and metabolic pathways, was found to drive NLRP3 and CLEC7A inflammasome activation, as well as prostaglandin secretion. In vitro stimulation with monosodium urate crystals revealed that the differentially expressed genes were enriched in S100Ahigh monocytes, highlighting the synergistic role of these pathways in driving gout inflammation. Additionally, gout genome-wide association study-prioritised genes underscored the role of fatty acid metabolism in inflammation, promoting prostaglandin secretion from S100Ahigh monocytes. CONCLUSIONS: These findings provide new insights into the role of CD14 monocytes in gout pathogenesis, particularly the contribution of hypoxia and fatty acid metabolism pathways, and suggest potential therapeutic targets for precision medicine in gout treatment.
引用
- Alaswad A, Cabău G, Crişan TO, et al. Integrative analysis reveals the multilateral inflammatory mechanisms of CD14 monocytes in gout. Ann Rheum Dis. 2025. PMID: 40023733. doi:10.1016/j.ard.2025.01.046
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。